MetrioPharm AG develops innovative therapies for infectious diseases on the basis of new and innovative medicines.
MetrioPharm AG is a stock exchange listed enterprise based in Zurich, Switzerland, which deals with the development and marketing of new pharmaceutical medicines in the advanced stage.
MetrioPharm has the patents for a new class of very effective medicines for the therapy of life-threatening infections as well as acute and chronic inflammable illnesses. Pharmaceutical drugs based on our medicine has already been approved in different countries.